Clinical Trial Update: Collagenase Option for Reduction of Dupuytren's Contracture in Japan [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update in Japan evaluates collagenase for reducing Dupuytren's contracture; trial completed and results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dupuytren Contracture

Drugs mentioned

• collagenase clostridium histolyticum (collagenase clostridium histolyticum)

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Dupuytren's Contracture | Phase 3 | Status: COMPLETED | Results posted: 2017-02-14